How Many Dexamethasone Doses Should Be Given Perioperatively?

Overview

About this study

The purpose of this study is to determine the most efficient and safest dexamethasone dose given perioperatively during total knee arthroplasty that reduces postoperative option consumption and pain, improves postoperative nausea and vomiting, and minimizes postoperative complications

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age > 18 years
  • Primary total knee arthroplasty

Exclusion Criteria:

  • Same day discharge
  • Age < 18 year
  • Revision or unicompartmental knee arthroplasty
  • Corticosteroid use within 3 months prior to TKA
  • Inflammatory arthritis
  • Current systemic fungal infection
  • Renal or liver failure
  • Prior adverse reaction to corticosteroid
  • Primary TKA requiring hardware removal

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated07/30/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Charles Hannon, M.D., M.B.A.

Contact us for the latest status

Contact information:

Erin Hennessey

(507) 284-1975

Hennessey.Erin@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20576294

Mayo Clinic Footer